Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 280

Indi Molecular meets Merck for series A

Merck unit M Ventures co-led an $11.5m round for the antibody replacement technology developer with corporate-sponsored firm Legend Capital.

Jul 5, 2017

Shougang helps reinforce Zhaogang with $73m

Zhaogang has secured $73m in funding from investors including a Shougang-backed fund, countering reports last year that it was gearing up for an initial public offering.

Jul 5, 2017

Danke Apartment houses series A+ cash

URWork has contributed to a $14.7m round for apartment rental portal Danke Apartment, which will use the capital to expand into three new Chinese markets.

Jul 4, 2017

Vector rockets to $21m series A

The Kanematsu-backed satellite launch services startup has now raised $31m altogether and will use the capital to fund upcoming commercial and passenger launches.

Jul 4, 2017

Spotinst positions itself for $15m series A

Intel Capital led the cloud infrastructure technology startup's series A round, which will support product development and international sales and marketing.

Jul 4, 2017

Independent Aftersales receives $41m service

China Harmony New Energy Auto Holding has spun out Independent Aftersales with $41.2m of funding, much of which came from Leaguer Auto and Aouto Investment.

Jul 4, 2017

TCL helps Wonder reach $14m in funding

The stealth-stage mobile gaming hardware developer has reportedly raised $14m in total, closing a series A round co-led by TCL Communication.

Jul 3, 2017

Mitoconix brainstorms $20m series A

Mitoconix, which is developing neurodegenerative treatments, was founded by the Johnson & Johnson and Takeda-backed FutuRx incubator.

Jun 30, 2017

Your.MD makes $10m appointment

Orkla Ventures was among the investors as medical information portal Your.MD closed a round that will support the deployment of its OneStop Health platform.

Jun 30, 2017
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here